Cargando…
PCSK9 and carbohydrate metabolism: A double-edged sword
Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a paramount role in the degradation of low-density lipoprotein (LDL) receptors (LDLR) on the hepatic cells surface and subsequently affects LDL particles catabolism and LDL cholesterol (LDL-c) levels. The anti-PCSK9 monoclonal antibodies le...
Autores principales: | Filippatos, Theodosios D, Filippas-Ntekouan, Sebastian, Pappa, Eleni, Panagiotopoulou, Thalia, Tsimihodimos, Vasilios, Elisaf, Moses S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507827/ https://www.ncbi.nlm.nih.gov/pubmed/28751953 http://dx.doi.org/10.4239/wjd.v8.i7.311 |
Ejemplares similares
-
LDL cholesterol estimation in patients with the metabolic syndrome
por: Gazi, Irene, et al.
Publicado: (2006) -
Effects of increased body weight and short-term weight loss on serum PCSK9 levels – a prospective pilot study
por: Filippatos, Theodosios D, et al.
Publicado: (2017) -
Double-edged sword.
Publicado: (1994) -
Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes
por: Christopoulou, Eliza, et al.
Publicado: (2019) -
The double-edged sword of evolution
por: Kruzel-Davila, Etty, et al.
Publicado: (2017)